Prognostic role of epidermal growth factor receptor in head and neck cancer: A meta-analysis

Journal of Surgical Oncology

Volumn 108, Issue 6, 2013, Pages 387-397

  Zhu, Xiaoli ^a   Zhang, Fengmei ^b   Zhang, Wei ^b,c   He, Jing ^b   Zhao, Yulan ^b   Chen, Xingming ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b EAST CHINA NORMAL UNIVERSITY   (China)

^c WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

epidermal growth factor receptor; head and neck cancer; prognosis

Indexed keywords

GROWTH FACTOR RECEPTOR;

ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER SPECIFIC SURVIVAL; CANCER SURVIVAL; COPY NUMBER VARIATION; DISEASE FREE SURVIVAL; DISEASE SPECIFIC SURVIVAL; GENE OVEREXPRESSION; HEAD AND NECK CANCER; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; LARYNGEAL SQUAMOUS CELL CANCER; METASTASIS FREE SURVIVAL; NASOPHARYNX CARCINOMA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION; RECURRENCE FREE SURVIVAL;

EPIDERMAL GROWTH FACTOR RECEPTOR; HEAD AND NECK CANCER; PROGNOSIS;

CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; GENE DOSAGE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAD AND NECK NEOPLASMS; HUMANS; KAPLAN-MEIER ESTIMATE; OBSERVATIONAL STUDY AS TOPIC; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 84886770343     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23406     Document Type: Article

References (86)

1. Argiris A, Karamouzis MV, Raben D, et al.: Head and neck cancer. Lancet 2008; 371: 1695-1709.
2. Parkin DM, Bray F, Ferlay J, et al.: Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108.
3. Sahu N, Grandis JR:, New advances in molecular approaches to head and neck squamous cell carcinoma. Anticancer Drugs 2011; 22: 656-664.
4. Jin G:, Using biomarkers to detect oral cancer holds potential for saving lives when the cancer is most curable. Biomark Med 2010; 4: 835-838.
5. Chang SS, Califano J:, Current status of biomarkers in head and neck cancer. J Surg Oncol 2008; 97: 640-643.
6. Hynes NE, Lane HA:, ERBB receptors and cancer: The complexity of targeted inhibitors. Nat Rev Cancer 2005; 5: 341-354.
7. Nicholson RI, Gee JM, Harper ME:, EGFR and cancer prognosis. Eur J Cancer 2001; 37 (Suppl 4): S9-S15.
8. Ozanne B, Richards CS, Hendler F, et al.: Over-expression of the EGF receptor is a hallmark of squamous cell carcinomas. J Pathol 1986; 149: 9-14.
9. Leemans CR, Braakhuis BJ, Brakenhoff RH:, The molecular biology of head and neck cancer. Nat Rev Cancer 2011; 11: 9-22.
10. Chung CH, Zhang Q, Hammond EM, et al.: Integrating epidermal growth factor receptor assay with clinical parameters improves risk classification for relapse and survival in head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 2011; 81: 331-338.
11. Hong A, Dobbins T, Lee CS, et al.: Relationships between epidermal growth factor receptor expression and human papillomavirus status as markers of prognosis in oropharyngeal cancer. Eur J Cancer 2010; 46: 2088-2096.
12. Agra IM, Carvalho AL, Pinto CA, et al.: Biological markers and prognosis in recurrent oral cancer after salvage surgery. Arch Otolaryngol Head Neck Surg 2008; 134: 743-749.
13. Wheeler S, Siwak DR, Chai R, et al.: Tumor epidermal growth factor receptor and EGFR PY1068 are independent prognostic indicators for head and neck squamous cell carcinoma. Clin Cancer Res 2012; 18: 2278-2289.
14. Aebersold DM, Froehlich SC, Jonczy M, et al.: Expression of transforming growth factor-alpha, epidermal growth factor receptor and platelet-derived growth factors A and B in oropharyngeal cancers treated by curative radiation therapy. Radiother Oncol 2002; 63: 275-283.
15. Huang TL, Li CF, Huang HY, et al.: Correlations between expression of epidermal growth factor receptor (EGFR), phosphorylated EGFR, cyclooxygenase-2 and clinicopathological variables and treatment outcomes in nasopharyngeal carcinomas. Chang Gung Med J 2010; 33: 619-627.
16. Shiraki M, Odajima T, Ikeda T, et al.: Combined expression of p53, cyclin D1 and epidermal growth factor receptor improves estimation of prognosis in curatively resected oral cancer. Mod Pathol 2005; 18: 1482-1489.
17. Weinstein IB, Joe A:, Oncogene addiction. Cancer Res 2008; 68: 3077-3080; discussion 3080.
18. Nakata Y, Uzawa N, Takahashi K, et al.: EGFR gene copy number alteration is a better prognostic indicator than protein overexpression in oral tongue squamous cell carcinomas. Eur J Cancer 2011; 47: 2364-2372.
19. Stroup DF, Berlin JA, Morton SC, et al.: Meta-analysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283: 2008-2012.
20. Parmar MK, Torri V, Stewart L:, Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med 1998; 17: 2815-2834.
21. Egger M, Smith GD, Phillips AN:, Meta-analysis: Principles and procedures. BMJ 1997; 315: 1533-1537.
22. Almadori G, Cadoni G, Galli J, et al.: Epidermal growth factor receptor expression in primary laryngeal cancer: An independent prognostic factor of neck node relapse. Int J Cancer 1999; 84: 188-191.
23. Moore RL, Dai Y, Faller DV:, Sirtuin 1 (SIRT1) and steroid hormone receptor activity in cancer. J Endocrinol 2012; 213: 37-48.
24. Al-Swiahb JN, Huang CC, Fang FM, et al.: Prognostic impact of p16, p53, epidermal growth factor receptor, and human papillomavirus in oropharyngeal cancer in a betel nut-chewing area. Arch Otolaryngol Head Neck Surg 2010; 136: 502-508.
25. Ang KK, Berkey BA, Tu X, et al.: Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma. Cancer Res 2002; 62: 7350-7356.
26. Bellacosa A, Almadori G, Cavallo S, et al.: Cyclin D1 gene amplification in human laryngeal squamous cell carcinomas: Prognostic significance and clinical implications. Clin Cancer Res 1996; 2: 175-180.
27. Cao XJ, Hao JF, Yang XH, et al.: Prognostic value of expression of EGFR and nm23 for locoregionally advanced nasopharyngeal carcinoma. Med Oncol 2012; 29: 263-271.
28. Chau NG, Perez-Ordonez B, Zhang K, et al.: The association between EGFR variant III, HPV, p16, c-MET, EGFR gene copy number and response to EGFR inhibitors in patients with recurrent or metastatic squamous cell carcinoma of the head and neck. Head Neck Oncol 2011; 3: 11.
29. Chen IH, Chang JT, Liao CT, et al.: Prognostic significance of EGFR and Her-2 in oral cavity cancer in betel quid prevalent area cancer prognosis. Br J Cancer 2003; 89: 681-686.
30. Chua DT, Nicholls JM, Sham JS, et al.: Prognostic value of epidermal growth factor receptor expression in patients with advanced stage nasopharyngeal carcinoma treated with induction chemotherapy and radiotherapy. Int J Radiat Oncol Biol Phys 2004; 59: 11-20.
31. Chung CH, Ely K, McGavran L, et al.: Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas. J Clin Oncol 2006; 24: 4170-4176.
32. Dassonville O, Formento JL, Francoual M, et al.: Expression of epidermal growth factor receptor and survival in upper aerodigestive tract cancer. J Clin Oncol 1993; 11: 1873-1878.
33. Demiral AN, Sarioglu S, Birlik B, et al.: Prognostic significance of EGF receptor expression in early glottic cancer. Auris Nasus Larynx 2004; 31: 417-424.
34. Etienne-Grimaldi MC, Pereira S, Magne N, et al.: Analysis of the dinucleotide repeat polymorphism in the epidermal growth factor receptor (EGFR) gene in head and neck cancer patients. Ann Oncol 2005; 16: 934-941.
35. Ettl T, Schwarz S, Kleinsasser N, et al.: Overexpression of EGFR and absence of C-KIT expression correlate with poor prognosis in salivary gland carcinomas. Histopathology 2008; 53: 567-577.
36. Fang FM, Li CF, Chien CY, et al.: Immunohistochemical expression of epidermal growth factor receptor and cyclooxygenase-2 in pediatric nasopharyngeal carcinomas: No significant correlations with clinicopathological variables and treatment outcomes. Int J Pediatr Otorhinolaryngol 2007; 71: 447-455.
37. Fei J, Hong A, Dobbins TA, et al.: Prognostic significance of vascular endothelial growth factor in squamous cell carcinomas of the tonsil in relation to human papillomavirus status and epidermal growth factor receptor. Ann Surg Oncol 2009; 16: 2908-2917.
38. Fujii M, Yamashita T, Ishiguro R, et al.: Significance of epidermal growth factor receptor and tumor associated tissue eosinophilia in the prognosis of patients with nasopharyngeal carcinoma. Auris Nasus Larynx 2002; 29: 175-181.
39. Furuta Y, Takasu T, Asai T, et al.: Clinical significance of the epidermal growth factor receptor gene in squamous cell carcinomas of the nasal cavities and paranasal sinuses. Cancer 1992; 69: 358-362.
40. Hama T, Yuza Y, Saito Y, et al.: Prognostic significance of epidermal growth factor receptor phosphorylation and mutation in head and neck squamous cell carcinoma. Oncologist 2009; 14: 900-908.
41. Hitt R, Ciruelos E, Amador ML, et al.: Prognostic value of the epidermal growth factor receptor (EGRF) and p53 in advanced head and neck squamous cell carcinoma patients treated with induction chemotherapy. Eur J Cancer 2005; 41: 453-460.
42. Hofman P, Butori C, Havet K, et al.: Prognostic significance of cortactin levels in head and neck squamous cell carcinoma: Comparison with epidermal growth factor receptor status. Br J Cancer 2008; 98: 956-964.
43. Huang SF, Cheng SD, Chien HT, et al.: Relationship between epidermal growth factor receptor gene copy number and protein expression in oral cavity squamous cell carcinoma. Oral Oncol 2012; 48: 67-72.
44. Jin T, Yu CX, Lei DP, et al.: Identification of epidermal growth factor receptor (EGFR) exon 20 single nucleotide polymorphism in Chinese squamous cell carcinoma of head and neck (SCCHN). Acta Otolaryngol 2009; 129: 1306-1312.
45. Katoh K, Nakanishi Y, Akimoto S, et al.: Correlation between laminin-5 gamma2 chain expression and epidermal growth factor receptor expression and its clinicopathological significance in squamous cell carcinoma of the tongue. Oncology 2002; 62: 318-326.
46. Kim YJ, Go H, Wu HG, et al.: Immunohistochemical study identifying prognostic biomolecular markers in nasopharyngeal carcinoma treated by radiotherapy. Head Neck 2011; 33: 1458-1466.
47. Kong A, Leboucher P, Leek R, et al.: Prognostic value of an activation state marker for epidermal growth factor receptor in tissue microarrays of head and neck cancer. Cancer Res 2006; 66: 2834-2843.
48. Kumar B, Cordell KG, Lee JS, et al.: EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer. J Clin Oncol 2008; 26: 3128-3137.
49. Laimer K, Spizzo G, Gastl G, et al.: High EGFR expression predicts poor prognosis in patients with squamous cell carcinoma of the oral cavity and oropharynx: A TMA-based immunohistochemical analysis. Oral Oncol 2007; 43: 193-198.
50. Leong JL, Loh KS, Putti TC, et al.: Epidermal growth factor receptor in undifferentiated carcinoma of the nasopharynx. Laryngoscope 2004; 114: 153-157.
51. Licitra L, Mesia R, Rivera F, et al.: Evaluation of EGFR gene copy number as a predictive biomarker for the efficacy of cetuximab in combination with chemotherapy in the first-line treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck: EXTREME study. Ann Oncol 2011; 22: 1078-1087.
52. Lindquist D, Ahrlund-Richter A, Tarjan M, et al.: Intense CD44 expression is a negative prognostic factor in tonsillar and base of tongue cancer. Anticancer Res 2012; 32: 153-161.
53. Magne N, Pivot X, Bensadoun RJ, et al.: The relationship of epidermal growth factor receptor levels to the prognosis of unresectable pharyngeal cancer patients treated by chemo-radiotherapy. Eur J Cancer 2001; 37: 2169-2177.
54. Maiorano E, Favia G, Maisonneuve P, et al.: Prognostic implications of epidermal growth factor receptor immunoreactivity in squamous cell carcinoma of the oral mucosa. J Pathol 1998; 185: 167-174.
55. Maurizi M, Scambia G, Benedetti Panici P, et al.: EGF receptor expression in primary laryngeal cancer: Correlation with clinico-pathological features and prognostic significance. Int J Cancer 1992; 52: 862-866.
56. Maurizi M, Almadori G, Ferrandina G, et al.: Prognostic significance of epidermal growth factor receptor in laryngeal squamous cell carcinoma. Br J Cancer 1996; 74: 1253-1257.
57. Monteiro LS, Bento MJ, Palmeira C, et al.: Epidermal growth factor receptor immunoexpression evaluation in malignant salivary gland tumours. J Oral Pathol Med 2009; 38: 508-513.
58. Monteiro LS, Diniz-Freitas M, Garcia-Caballero T, et al.: EGFR and Ki-67 expression in oral squamous cell carcinoma using tissue microarray technology. J Oral Pathol Med 2010; 39: 571-578.
59. Morrison LE, Jacobson KK, Friedman M, et al.: Aberrant EGFR and chromosome 7 associate with outcome in laryngeal cancer. Laryngoscope 2005; 115: 1212-1218.
60. Numico G, Russi EG, Colantonio I, et al.: EGFR status and prognosis of patients with locally advanced head and neck cancer treated with chemoradiotherapy. Anticancer Res 2010; 30: 671-676.
61. Parikh RR, Yang Q, Haffty BG:, Prognostic significance of vascular endothelial growth factor protein levels in T1-2 N0 laryngeal cancer treated with primary radiation therapy. Cancer 2007; 109: 566-573.
62. Pectasides E, Rampias T, Kountourakis P, et al.: Comparative prognostic value of epidermal growth factor quantitative protein expression compared with FISH for head and neck squamous cell carcinoma. Clin Cancer Res 2011; 17: 2947-2954.
63. Pivot X, Magne N, Guardiola E, et al.: Prognostic impact of the epidermal growth factor receptor levels for patients with larynx and hypopharynx cancer. Oral Oncol 2005; 41: 320-327.
64. Psyrri A, Yu Z, Weinberger PM, et al.: Quantitative determination of nuclear and cytoplasmic epidermal growth factor receptor expression in oropharyngeal squamous cell cancer by using automated quantitative analysis. Clin Cancer Res 2005; 11: 5856-5862.
65. Ranelletti FO, Almadori G, Rocca B, et al.: Prognostic significance of cyclooxygenase-2 in laryngeal squamous cell carcinoma. Int J Cancer 2001; 95: 343-349.
66. Reimers N, Kasper HU, Weissenborn SJ, et al.: Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer. Int J Cancer 2007; 120: 1731-1738.
67. Rubin Grandis J, Melhem MF, Gooding WE, et al.: Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival. J Natl Cancer Inst 1998; 90: 824-832.
68. Ryott M, Wangsa D, Heselmeyer-Haddad K, et al.: EGFR protein overexpression and gene copy number increases in oral tongue squamous cell carcinoma. Eur J Cancer 2009; 45: 1700-1708.
69. Shah NG, Trivedi TI, Tankshali RA, et al.: Prognostic significance of molecular markers in oral squamous cell carcinoma: A multivariate analysis. Head Neck 2009; 31: 1544-1556.
70. Shi W, Kato H, Perez-Ordonez B, et al.: Comparative prognostic value of HPV16 E6 mRNA compared with in situ hybridization for human oropharyngeal squamous carcinoma. J Clin Oncol 2009; 27: 6213-6221.
71. Smid EJ, Stoter TR, Bloemena E, et al.: The importance of immunohistochemical expression of EGFr in squamous cell carcinoma of the oral cavity treated with surgery and postoperative radiotherapy. Int J Radiat Oncol Biol Phys 2006; 65: 1323-1329.
72. Smith BD, Smith GL, Carter D, et al.: Molecular marker expression in oral and oropharyngeal squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 2001; 127: 780-785.
73. Storkel S, Reichert T, Reiffen KA, et al.: EGFR and PCNA expression in oral squamous cell carcinomas-a valuable tool in estimating the patient's prognosis. Eur J Cancer B Oral Oncol 1993; 29B: 273-277.
74. Szabo B, Nelhubel GA, Karpati A, et al.: Clinical significance of genetic alterations and expression of epidermal growth factor receptor (EGFR) in head and neck squamous cell carcinomas. Oral Oncol 2011; 47: 487-496.
75. Taheri-Kadkhoda Z, Magnusson B, Svensson M, et al.: Expression modes and clinical manifestations of latent membrane protein 1, Ki-67, cyclin-B1, and epidermal growth factor receptor in nonendemic nasopharyngeal carcinoma. Head Neck 2009; 31: 482-492.
76. Tinhofer I, Klinghammer K, Weichert W, et al.: Expression of amphiregulin and EGFRvIII affect outcome of patients with squamous cell carcinoma of the head and neck receiving cetuximab-docetaxel treatment. Clin Cancer Res 2011; 17: 5197-5204.
77. Trivedi TI, Tankshali RA, Goswami JV, et al.: Identification of site-specific prognostic biomarkers in patients with oral squamous cell carcinoma. Neoplasma 2011; 58: 217-226.
78. Wen QH, Miwa T, Yoshizaki T, et al.: Prognostic value of EGFR and TGF-alpha in early laryngeal cancer treated with radiotherapy. Laryngoscope 1996; 106: 884-888.
79. Young RJ, Rischin D, Fisher R, et al.: Relationship between epidermal growth factor receptor status, p16(INK4A), and outcome in head and neck squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 2011; 20: 1230-1237.
80. Xia W, Lau YK, Zhang HZ, et al.: Combination of EGFR, HER-2/neu, and HER-3 is a stronger predictor for the outcome of oral squamous cell carcinoma than any individual family members. Clin Cancer Res 1999; 5: 4164-4174.
81. Yuan Y, Zhou X, Song J, et al.: Expression and clinical significance of epidermal growth factor receptor and type 1 insulin-like growth factor receptor in nasopharyngeal carcinoma. Ann Otol Rhinol Laryngol 2008; 117: 192-200.
82. Hayes DF, Isaacs C, Stearns V:, Prognostic factors in breast cancer: Current and new predictors of metastasis. J Mammary Gland Biol Neoplasia 2001; 6: 375-392.
83. Soonthornthum T, Arias-Pulido H, Joste N, et al.: Epidermal growth factor receptor as a biomarker for cervical cancer. Ann Oncol 2011; 22: 2166-2178.
84. Reiner A, Spona J, Reiner G, et al.: Estrogen receptor analysis on biopsies and fine-needle aspirates from human breast carcinoma. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies. Am J Pathol 1986; 125: 443-449.
85. Remmele W, Schicketanz KH:, Immunohistochemical determination of estrogen and progesterone receptor content in human breast cancer. Computer-assisted image analysis (QIC score) vs. subjective grading (IRS). Pathol Res Pract 1993; 189: 862-866.
86. Trilling GM, Cho H, Ugas MA, et al.: Spinal metastasis in head and neck cancer. Head Neck Oncol 2012; 4: 36.